Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Enlaza Therapeutics

Request full access

A biotechnology research company

San Diego, United StatesFounded 2020Biotech & Life Sciences

About Enlaza Therapeutics

Enlaza Therapeutics, founded by Dr. Duron, is a trailblazer in the field of covalent biologics. The company is focused on developing a new generation of protein therapeutics using its proprietary platform. These innovative treatments are designed to be more effective and safer for patients, offering a significant advancement in the biotech industry.

The company operates in the biotech market, specifically in the area of therapeutic proteins and biologics. Its target clients are primarily patients who can benefit from their novel therapies. The business model of Enlaza revolves around the development, production, and distribution of these cutting-edge protein therapeutics.

Dr. Duron, with his extensive experience in venture-backed biotech and a history of successful acquisitions, leads the company. He is supported by a team of seasoned biopharmaceutical professionals, including Lei Wang, a renowned professor in the field of pharmaceutical chemistry.

Enlaza generates revenue through the commercialization of its innovative protein therapeutics. The company's financial health is likely to be bolstered by the high demand for more effective and safer treatments in the healthcare sector.

In summary, Enlaza Therapeutics is a pioneering biotech company with a focus on developing novel protein therapeutics. It is led by a team of experienced professionals and operates in a market with high growth potential.

Source: Dealroom company data

At a glance

Status
Operational
Employees
67
Open positions
3
Dealroom signal
87.2/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Spinout, Biotech and Pharma, proteomics, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VCOther financing Sep 2025 $0 — Undisclosed —
SERIES AOther financing Apr 2024 $100M $400M Lightspeed Venture Partners · Avalon Ventures · Pappas Capital · Samsara BioCapital ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Enlaza Therapeutics website traffic

Latest recorded traffic for Enlaza Therapeutics is 2K monthly website visits, down 4.8% over the last three months. Enlaza Therapeutics's team grew 11.7% over the past year.

Latest monthly visits2K 3-month web change-4.8% 1-year team growth+11.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Enlaza Therapeutics in the San Diego ecosystem

Live from Dealroom

The Enlaza Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

14 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed5 investors entered at this stage

Series A7 investors entered at this stage

  • J.P. Morgan Asset Management
  • Pappas Capital
  • Frazier Life Sciences
  • Amgen Ventures
  • Alexandria Venture Investments
  • Bregua Corporation
  • Regeneron Ventures

Other known investors2 additional known investors

  • Scripps Translational Science Institute
  • University of California, San Francisco
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Enlaza Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Enlaza Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.